Mohamed Ibrahim Mohamed El-Sayed

South Egypt Cancer Institute

Assiut University

Department
Department of Radiotherapy and Nuclear medicine
Fax No
0882348612
Email:
mohebel@yahoo.co.uk
MIS Email
mohamed.elsayed@oncology.au.edu.eg
Mobile
01222953887
Office
N/A - 04324
Google Scholar
google_scholar
M.D. In () , , 2006

Professor South Egypt Cancer Institute, ِِAssiut University , 2016

Associate Professor South Egypt Cancer Institute, ِِAssiut University , 2011

Lecturer South Egypt Cancer Institute, Assiut University , 2006

Assistant Lecturer South Egypt Cancer Institute, Assiut University , 2001

Head South Egypt Cancer Institute, Assiut University ,since 2011-06-04
# Title Research Year
1 Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients 		2016
2 Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients 		2016
3 The Effects Of Paraffin Wedge Filters On The Electron Beam Therapy 2016
4 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
5 The Effects Of Paraffin Wedge Filters On The Electron Beam Therapy 2016
6 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. 2016
7 The Effects Of Paraffin Wedge Filters On The Electron Beam Therapy 2016
8 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
9 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. 2016
10 Chemoradiation Compared to Surgery Alone in Patients With Non-Metastatic Esophageal Carcinoma 2015
11 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. 2015
12 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. 2015
13 A Retrospective Study of Survival and Patterns of Failure in Gastric Cancer after Adjuvant Chemoradiation 2014
14 Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era 2014
15 Single fraction compared with multiple fraction re-irradiations in patients with painful bone metastases 2013
16 Electron Virtual Wedge: Validation and Dosimetric Evaluation 2013
17 Single Fraction Compared with Multiple Fraction Re-Irradiations in
Patients with Painful Bone Metastases 		2013
18 Experimental Study of Using Wax Wedge Filter in Electron Beams 2013
19 Quality of Life in Bladder Cancer Patients Treated with Radical
Cystectomy and Orthotopic Bladder Reconstruction versus Bladder
Preservation Protocol 		2013
20 Adjuvant radiotherapy in breast cancer:A comparison of two accelerated hypofractionated protocols 2013
21 Comparison of Hypofractionated and Conventional Radiotherapy
Protocols in Breast Cancer Patients: A Retrospective Study 		2012
22 Combined Modality Therapy of Pediatric Wilms' Tumor in Upper Egypt: A Retrospective Study 2012
23 Survival Analysis in Patients with Nonmetastatic
Squamous Cell Carcinoma of
the Urinary Bladder 		2011
24 Survival Analysis in Patients with Non-metastatic Squamous Cell Carcinoma of the Urinary Bladder
 		2011
25 Survival Analysis in Patients with Non-metastatic Squamous Cell Carcinoma of the Urinary Bladder
 		2011
26 Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: A retrospective study 2010
27 Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial 2010
28 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma 2009
1- Noha Ali abdelmalik , Hypofractionated versus conventional radiotherapy with concurrent Gemcitabine in bladder preservation of patient with bladder carcinoma ,2016-07-17
supervisor: -Professor Dr. Samir Eid Shehata Professor of clinical Oncology Head of clinical oncology department, Assuit University Hospital, Assuit University. -prof. Mohamed Ibraheem Mohamed Professor of Radiation Oncology, South Egypt Cancer Institute, Assiu

2- SHAIMA ELSAYED YOUSSIF AHMAD , ADJUVANT RADIOTHERAPY IN BREAT CANCER ACOMPARISON OF TWO ACCELERATED HYPOFRACTIONATED PROTOCOLS ,2013-06-30
supervisor: SAMIR SHEHATA, MOHAMED IBRAHIM ELSAYED, MOSTAFA EL-SAYED ABD-EL-WANIS

3- Salwa Fathy Mohamed , Accelerated Radiation Therapy, Six fractions Per Week, For Squamous Cell Carcinoma of Head and Neck ,2012-06-30
supervisor: Samir Shehata Mohamed, Mohamed Ebrahim Mohamed El-Said, Mostafa El-Said Abd-Elwanees

الجمعيات العلمية و النقابات :